EUVIMEDEUVIMED entdecken
Open Access

MNX1-AS1 suppresses chemosensitivity by activating the PI3K/AKT pathway in breast cancer

You Shuai, Zhonghua Ma, Jian Yue, Chunxiao Li, Jie Ju, Xue Wang, Haili Qian, Peng Yuan

International Journal of Biological Sciences · 2025

DOI: 10.7150/ijbs.104483 ↗

Kurz gefasst

Fachartikel in der Zeitschrift International Journal of Biological Sciences, 2025. Verfasst von You Shuai und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Medical Oncology, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Scien…. Hauptthemen laut MEDLINE: Breast Neoplasms, Proto-Oncogene Proteins c-akt, Phosphatidylinositol 3-Kinases, RNA, Long Noncoding. Die Arbeit wurde bisher 11-mal zitiert (Crossref). Der Volltext ist frei in PubMed Central verfügbar.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Breast NeoplasmsProto-Oncogene Proteins c-aktPhosphatidylinositol 3-KinasesRNA, Long NoncodingHumansFemaleAnimalsMiceSignal TransductionCell Line, TumorDrug Resistance, NeoplasmGene Expression Regulation, NeoplasticMice, NudeY-Box-Binding Protein 1Mice, Inbred BALB C

Stichwörter der Autor:innen

ITGA6/PI3K/AKT pathwayLncRNAbreast cancerchemosensitivitylipid nanoparticles

Substanzen

Proto-Oncogene Proteins c-aktPhosphatidylinositol 3-KinasesRNA, Long NoncodingY-Box-Binding Protein 1YBX1 protein, human

Autor:innen und Institutionen

  • Department of Medical Oncology, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, 100021, China.
  • Key Laboratory of Carcinogenesis and Translational Research (Ministry of Education), Department of Endoscopy, Peking University Cancer Hospital & Institute, Beijing, 100142, China.
  • Department of VIP Medical Services, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, 100021, China.
  • State Key Laboratory of Molecular Oncology, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, 100021, Chi…

Zitieren

APA

Shuai, Y., Ma, Z., Yue, J., Li, C., Ju, J., Wang, X., Qian, H., & Yuan, P. (2025). MNX1-AS1 suppresses chemosensitivity by activating the PI3K/AKT pathway in breast cancer. International Journal of Biological Sciences. https://doi.org/10.7150/ijbs.104483

Vancouver

Shuai Y, Ma Z, Yue J, Li C, Ju J, Wang X, et al. MNX1-AS1 suppresses chemosensitivity by activating the PI3K/AKT pathway in breast cancer. International Journal of Biological Sciences. 2025. doi:10.7150/ijbs.104483

BibTeX
@article{Shuai2025,
  author = {Shuai, You and Ma, Zhonghua and Yue, Jian and Li, Chunxiao and Ju, Jie and Wang, Xue and Qian, Haili and Yuan, Peng},
  title = {MNX1-AS1 suppresses chemosensitivity by activating the PI3K/AKT pathway in breast cancer},
  journal = {International Journal of Biological Sciences},
  year = {2025},
  doi = {10.7150/ijbs.104483}
}
Kostenlos starten →